Diffusion-weight imaging (DWI) is a form of magnetic resonance imaging (MRI) that is used to detect early changes in brain tissue at the cellular level. DWI is typically done before abnormalities appear on conventional imaging. In litigation involving acute brain injury, DWI becomes central to the evidentiary record because it can provide time-sensitive insight into […]
Diagnostic delay is not, in itself, a basis for liability. Legal inquiry begins when a delay can be shown to have altered the clinical course in a way that produced permanent neurological injury. Courts evaluating these cases focus on whether a condition was identifiable within a clinically meaningful window, whether appropriate diagnostic steps were taken […]
Causation analysis in brain injury cases becomes materially more complex where a metabolic disorder is present. Metabolic conditions, whether genetic or acquired, can independently produce neurological impairment, alter the brain’s response to injury, or affect recovery trajectories. Courts evaluating such cases do not assume a single cause. The inquiry instead requires a structured assessment of […]
Root cause analysis, or RCA, is a structured method used within healthcare systems to examine adverse events and identify the underlying factors that contributed to their occurrence. However, in litigation, RCA is not evaluated as a definitive explanation for causation but as a means to provide context for a deviation in standard of care. Courts […]
Peer review in healthcare serves as an internal mechanism for evaluating clinical performance, identifying deviations from accepted practice, and implementing corrective measures to reduce the risk of future harm. There is significance of peer review in litigation, as well—not in its existence but in its function. Courts ask, “Did the peer review function as intended […]